Cargando…
A Novel Rab9 Effector Required for Endosome-to-TGN Transport
Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138197/ https://www.ncbi.nlm.nih.gov/pubmed/9230071 |
_version_ | 1782143507106889728 |
---|---|
author | Díaz, Elva Schimmöller, Frauke Pfeffer, Suzanne R. |
author_facet | Díaz, Elva Schimmöller, Frauke Pfeffer, Suzanne R. |
author_sort | Díaz, Elva |
collection | PubMed |
description | Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active form of Rab9. We report here the discovery of a 40-kD protein (p40) that binds Rab9–GTP with roughly fourfold preference to Rab9–GDP. p40 does not interact with Rab7 or K-Ras; it also fails to bind Rab9 when it is bound to GDI. The protein is found in cytosol, yet a significant fraction (∼30%) is associated with cellular membranes. Upon sucrose density gradient flotation, membrane- associated p40 cofractionates with endosomes containing mannose 6-phosphate receptors and the Rab9 GTPase. p40 is a very potent transport factor in that the pure, recombinant protein can stimulate, significantly, an in vitro transport assay that measures transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. The functional importance of p40 is confirmed by the finding that anti-p40 antibodies inhibit in vitro transport. Finally, p40 shows synergy with Rab9 in terms of its ability to stimulate mannose 6-phosphate receptor transport. These data are consistent with a model in which p40 and Rab9 act together to drive the process of transport vesicle docking. |
format | Text |
id | pubmed-2138197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21381972008-05-01 A Novel Rab9 Effector Required for Endosome-to-TGN Transport Díaz, Elva Schimmöller, Frauke Pfeffer, Suzanne R. J Cell Biol Article Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active form of Rab9. We report here the discovery of a 40-kD protein (p40) that binds Rab9–GTP with roughly fourfold preference to Rab9–GDP. p40 does not interact with Rab7 or K-Ras; it also fails to bind Rab9 when it is bound to GDI. The protein is found in cytosol, yet a significant fraction (∼30%) is associated with cellular membranes. Upon sucrose density gradient flotation, membrane- associated p40 cofractionates with endosomes containing mannose 6-phosphate receptors and the Rab9 GTPase. p40 is a very potent transport factor in that the pure, recombinant protein can stimulate, significantly, an in vitro transport assay that measures transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. The functional importance of p40 is confirmed by the finding that anti-p40 antibodies inhibit in vitro transport. Finally, p40 shows synergy with Rab9 in terms of its ability to stimulate mannose 6-phosphate receptor transport. These data are consistent with a model in which p40 and Rab9 act together to drive the process of transport vesicle docking. The Rockefeller University Press 1997-07-28 /pmc/articles/PMC2138197/ /pubmed/9230071 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Díaz, Elva Schimmöller, Frauke Pfeffer, Suzanne R. A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title | A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title_full | A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title_fullStr | A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title_full_unstemmed | A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title_short | A Novel Rab9 Effector Required for Endosome-to-TGN Transport |
title_sort | novel rab9 effector required for endosome-to-tgn transport |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138197/ https://www.ncbi.nlm.nih.gov/pubmed/9230071 |
work_keys_str_mv | AT diazelva anovelrab9effectorrequiredforendosometotgntransport AT schimmollerfrauke anovelrab9effectorrequiredforendosometotgntransport AT pfeffersuzanner anovelrab9effectorrequiredforendosometotgntransport AT diazelva novelrab9effectorrequiredforendosometotgntransport AT schimmollerfrauke novelrab9effectorrequiredforendosometotgntransport AT pfeffersuzanner novelrab9effectorrequiredforendosometotgntransport |